These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24126682)

  • 41. Sofosbuvir for treatment of chronic hepatitis C.
    Kattakuzhy S; Levy R; Kottilil S
    Hepatol Int; 2015 Apr; 9(2):161-73. PubMed ID: 25788194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemical genetics-based development of small molecules targeting hepatitis C virus.
    Jin G; Lee J; Lee K
    Arch Pharm Res; 2017 Sep; 40(9):1021-1036. PubMed ID: 28856597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies.
    Shahid I; ALMalki WH; Hafeez MH; Hassan S
    Crit Rev Microbiol; 2016 Aug; 42(4):535-47. PubMed ID: 25373616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.
    Tapper EB; Afdhal NH
    J Viral Hepat; 2013 Oct; 20(10):669-77. PubMed ID: 24010641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging therapeutic targets for hepatitis C virus infection.
    Jesudian AB; de Jong YP; Jacobson IM
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):612-9.e1. PubMed ID: 23583900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotype 1 hepatitis C virus and the pharmacist's role in treatment.
    Sebhatu P; Martin MT
    Am J Health Syst Pharm; 2016 Jun; 73(11):764-74. PubMed ID: 27126832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C.
    Bickerstaff C
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):787-800. PubMed ID: 26289734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene therapies for hepatitis C virus.
    Verstegen MM; Pan Q; van der Laan LJ
    Adv Exp Med Biol; 2015; 848():1-29. PubMed ID: 25757613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials.
    Lee LY; Tong CY; Wong T; Wilkinson M
    Int J Clin Pract; 2012 Apr; 66(4):342-55. PubMed ID: 22420497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials.
    Chary A; Holodniy M
    Rev Recent Clin Trials; 2010 Sep; 5(3):158-73. PubMed ID: 20482493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New approaches in the treatment of hepatitis C.
    González-Grande R; Jiménez-Pérez M; González Arjona C; Mostazo Torres J
    World J Gastroenterol; 2016 Jan; 22(4):1421-32. PubMed ID: 26819511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.
    Gentile I; Coppola N; Buonomo AR; Zappulo E; Borgia G
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1211-23. PubMed ID: 24848437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. REVIEW - Advancements in combination therapy of Hepatitis C virus.
    Jahangeer M; Ud Din NZ; Karim S; Hussain S; Ashiq M; Ali U; Ul Haq A; Munir N; Mahmood Z; Ghaffar A
    Pak J Pharm Sci; 2020 Sep; 33(5):2171-2178. PubMed ID: 33824126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viral resistance in HCV infection.
    Ceccherini-Silberstein F; Cento V; Di Maio VC; Perno CF; Craxì A
    Curr Opin Virol; 2018 Oct; 32():115-127. PubMed ID: 30439589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new era of therapy for hepatitis C virus infection.
    Nyalakonda H; Utay NS
    Curr Opin Infect Dis; 2015 Oct; 28(5):471-8. PubMed ID: 26203851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is the future of ribavirin therapy for hepatitis C?
    Koh C; Liang TJ
    Antiviral Res; 2014 Apr; 104():34-9. PubMed ID: 24468277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
    Kim SM; Song IH
    Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now.
    Florian J; Mishra P; Arya V; Harrington P; Connelly S; Reynolds KS; Sinha V
    Clin Pharmacol Ther; 2015 Oct; 98(4):394-402. PubMed ID: 26179495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HCV drug discovery aimed at viral eradication.
    Schinazi RF; Bassit L; Gavegnano C
    J Viral Hepat; 2010 Feb; 17(2):77-90. PubMed ID: 20040045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in and the future of treatments for hepatitis C.
    Cheng R; Tu T; Shackel N; McCaughan GW
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):633-47. PubMed ID: 24846594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.